logo
Contributor: What the ancient world can teach us about death

Contributor: What the ancient world can teach us about death

Yahoo24-04-2025

I first became fascinated by death when I was 8 and my mummy took me to the British Museum to look at the mummies. When, at a slightly older age, I began to study death and the ancient world what struck me most, despite many fascinating cultural variants, was the uniformity, and limitation of the human imagination over the millennia vis-à-vis what to expect when we're gone.
The COVID pandemic and its aftermath have killed more than 1,220,000 people in the U.S. alone, and this has made everybody more aware of death's omnipresence. But in the ancient world, you needed no such wake-up call. Your chances of celebrating your first birthday weren't much better than two in three. If you survived and were male, you could perhaps expect to reach your mid-40s. If you were female, your life expectancy dropped to your mid- to late 30s. A birthing mother's odds of surviving labor were grim. 'I'd rather fight in battle three times than give birth once,' says Medea, in the play by Euripides.
Big killers of the ancient world were bronchitis, gastroenteritis, tuberculosis, malaria and cholera, which affected people of all social status. Plague was a regular seasonal visitor, sometimes carrying off as much as a third of the population. Floods washed away entire settlements, and fire was an ever-present hazard. Earthquakes, too, took a very heavy toll. The Roman poet Horace's advice to 'seize the day' — carpe diem —could not have been more fitting.
Today, people have the option of dying in a hospital or in a hospice . But there was nothing remotely comparable to professional, institution-based palliative care in antiquity. If you didn't die in war or at sea, you breathed your last in the bosom of your family.
And except in Egypt and Rome, where the death industry was lively, undertakers were virtually unknown. Instead, the family, women especially, took care of the dead, washing and clothing the corpse in a shroud and preparing it for viewing in the home. Perhaps because of these intimacies, the funeral itself was anything but the solemn and muted affair it tends to be in our culture. Men and women beat their heads and breasts, poured dust on their hair, tore their clothing, rolled on the ground and bewailed their loss in a paroxysm of grief. Polytheistic religion had little to offer by way of comfort or consolation. How could it? The Olympian gods knew nothing of death and conducted themselves without any regard for mortality.
And yet, the ancients did have their share of ideas about the afterlife. Most believed that the dead not only continued to exist elsewhere but also, paradoxically, depended on sustenance deposited beside their remains. The modern practice of laying flowers on a grave is fueled by the same vague idea that the dead are contactable at the place where they are interred.
In Homer's 'Odyssey' everyone ends up in the same dank, dark, dreary region called Hades, irrespective of what lives they have led. Only a tiny minority — three people in total — get punished for being very bad. Tantalus, for instance, who cooked his son in a casserole and served him up to the gods, is 'tantalized' for eternity by food and drink that is always just out of his reach.
The idea of a dualistic afterlife with some kind of heaven for the blessed derives from the ancient Egyptians. According to them, before being admitted to the Field of Reeds, where you'll be able to hunt and party like there's no tomorrow, you have to appear before the underworld judge Osiris, who will cross-examine you to see if you've led a virtuous life. Your heart will be weighed on a scale, against a feather of truth. If it's heavier than the feather, a monster will devour you, but after that you'll simply cease to exist. No hell, in other words.
Over time, a number of Greeks came to believe that a blessed afterlife was available for those who had been initiated into the so-called mystery cults, though what exactly this blessedness amounted to is unclear. Over time, too, the belief that Hades was a place of punishment gained traction. Aeneas, making a pit stop on his way to catch up with his father in Hades, learns that numerous categories of criminals experience gruesome punishments. This anticipates the eternal fires that both Christianity and Islam suggest will consume the ungodly.
The late Pope Francis' comment relayed by a journalist back in 2018 — 'Hell does not exist; there is the disappearance of sinful souls' — was a welcome sign for sinners like myself, even though the Vatican quickly asserted that he wasn't speaking ex cathedra. By contrast, the Hebrew Bible shows little interest in the plight of individuals after death. Good and bad end up in Sheol, a region very similar to Hades.
Today, according to Pew Research Center data, some 80% of Americans believe in an afterlife. Their thoughts about what to expect there remain somewhat confused, but perhaps it's telling that the most commonly held idea is that they will be reunited with loved ones and — if they're lucky — with pets. That view, absent the pets, also prevailed in antiquity. Greek funerary monuments frequently show the dead, or the living and the dead, shaking hands. The same theme is evinced most movingly in Etruscan sarcophagi that depict husband and wife lying in bed together for all eternity. Not even the Egyptians came up with a better way of conveying the hope that the life awaiting us will be as sensual and as pleasurable as our best moments here on Earth.
If there's one thing I've learned studying all of this, it's that inconsistency and illogicality lie at the heart of the human effort to imagine what to expect when we're dead. Even some hardened atheists find it difficult to imagine extinction. The belief that humans will continue to exist in a different realm or on a different plane and that they will face a reckoning are ideas that have been around for thousands of years. So, too, has the belief that nothing survives death. 'I didn't exist. I existed. I don't exist. I don't care,' reads an epitaph often found on Roman gravestones.
Mark Twain put it equally memorably: 'I do not fear death. I had been dead for billions and billions of years before I was born, and hadn't suffered the slightest inconvenience.'
Robert Garland, professor emeritus of the classics at Colgate University, is the author, most recently, of 'What to Expect When You're Dead: An Ancient Tour of Death and the Afterlife.' This article was produced in partnership with Zocalo Public Square.
If it's in the news right now, the L.A. Times' Opinion section covers it. Sign up for our weekly opinion newsletter.
This story originally appeared in Los Angeles Times.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump's damage will take a generation to repair, but deaths can't be undone
Trump's damage will take a generation to repair, but deaths can't be undone

Yahoo

timean hour ago

  • Yahoo

Trump's damage will take a generation to repair, but deaths can't be undone

The damage Donald Trump has done to our 'Experiment in Democracy' will take a generation to repair. The damage he has inflicted on the health of Americans and people worldwide is criminal. In his first term, he politicized COVID. This extended the pandemic, leading to more deaths. The indiscriminate cuts to staff and funding of federal agencies and universities will hinder research on cancer cures, vaccinations and will stop life-saving experimental treatments. The best scientists will not want to work in this country. Canceling USAID, our most effective foreign aid, will be devastating. It will stop the children vaccinations in poor countries and treating epidemics worldwide before they can come to this country. It is unacceptable for pregnant women and children to contract preventable illness! David Nachamie, MD, Lincolnton For nine years, I served as a custody advocate with Council for Children's Rights (CFCR) — an organization that was a lifeline for vulnerable children and families in our courts. We conducted in-depth investigations: Are these children being abused? Are they eating? Are they being silenced? CFCR is closing one of its most important departments. It is heartbreaking and shameful. This department provided some of the best legal support and advocacy regardless of income or status. We served every child as if they were our own. When judges had no answers, we found them. Shame on us for not fighting harder. Shame on the silence that followed the tireless work of unpaid advocates who protected the voiceless. Who will take up this work and speak for these children? When we let this department fall, we abandoned those who needed us most. Melanie Dunston, Charlotte North Carolina just got left in the solar dust. With the U.S. House's budget scrapping clean energy tax credits, we're waving goodbye to billions in investment and thousands of good paying jobs. N.C. was building a reputation as a clean energy powerhouse. Now, we risk becoming the Blockbuster Video of energy innovation. This isn't just bad policy — it's economic self-sabotage. Farmers leasing land for solar, techs installing panels and engineers building wind grids all stand to lose. The planet doesn't get a do-over. Let's not pull the plug on progress. We need a budget that backs clean energy. The Big Beautiful Bill is only Big. Lost NC jobs and investments are not beautiful — neither is a dirtier climate. Jane Taylor, Charlotte The U.S. credit rating for its mounting debt got lowered while the president and the Republican Party push for reduced tax rates for the wealthiest Americans. Only in America! Tom Bowers, Charlotte Charlotte Area Transit System (CATS) deserves praise for its flawless execution of free spectator transportation from its I-485/Sharon Rd station to the PGA Championship. My experience to and from Quail Hollow was short wait times, very clean transportation and friendly staff. Thank you to CATS staff and leadership who made this service seamless and pleasant. Mark Doby, Salisbury Trump's trade games create less security for businesses and citizens. Trump calls his 'Art of the deal' trade negotiations 'brilliant,' but the brilliance of our economy is in question with his whiplash approach. Listening to small to mid-size business owners and CEOs, it sounds like they are having huge problems pricing products and communicating with customers about pricing. This can lead to far less profit, layoffs, and even bankruptcies. Just not knowing if a tariff is off or on makes planning difficult. Customers of all kinds of business to business products and business to consumer products are stocking up ahead of tariffs or keeping their powder dry until they can see a way ahead that has certainty. This is a system of capitalism, and it seems Trump is unaware of the pain his whiplash approach is inflicting. Katherine Nelson, Rock Hill

Terrible News for Pfizer Stock Investors
Terrible News for Pfizer Stock Investors

Yahoo

timean hour ago

  • Yahoo

Terrible News for Pfizer Stock Investors

While it no longer generates the sales it once did, Pfizer's coronavirus lineup remains critical to its results. However, recent regulatory changes in the U.S. should make this franchise somewhat less lucrative. Even so, Pfizer's hopes of a comeback lie elsewhere, especially in its improving oncology unit. 10 stocks we like better than Pfizer › The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction, as has the company's share price. The stock is down by 56% since 2022. Although Pfizer has made some efforts to turn things around, they have been insufficient. And recent regulatory developments in the U.S. somewhat complicate things for the drugmaker. Here's what investors need to know. Pfizer's poor performance since 2022 is largely due to its coronavirus portfolio. After producing record revenue thanks to its work in this area, once the pandemic started receding, sales from Comirnaty, its COVID-19 vaccine, and Paxlovid, its therapy for the disease, started dropping off a cliff. However, Pfizer's coronavirus franchise has remained critical to its overall financial results. In 2024, the company's combined revenue from Paxlovid and Comirnaty was $11.1 billion. Pfizer's total top line came in at $63.6 billion, increasing 7% compared to the year-ago period. When excluding contributions from its coronavirus products, Pfizer's revenue grew more quickly -- by 12% year over year. The company's sales were down compared to 2023 but still accounted for about 17.5% of its top line. That's a meaningful amount. Pfizer would be in a lot more trouble without Paxlovid and Comirnaty. Here's the problem: Recent regulatory changes in the U.S. will make it more challenging for Pfizer to consistently generate solid revenue from Comirnaty. The U.S. Food and Drug Administration (FDA) has decided that instead of recommending COVID-19 vaccines for healthy adults and children above a certain age, it will do so only for seniors aged 65 and older and those with certain medical conditions that put them at risk of severe disease outcomes. The agency is requiring additional clinical trials before it can recommend annual booster shots for healthy adults. Healthy children and pregnant women are also no longer on the list of those who should take the vaccine. These changes will take effect in the fall, peak vaccination season for COVID-19. In other words, the U.S. coronavirus vaccine market just became smaller. What does this mean for investors? Pfizer's coronavirus franchise might weaken somewhat as a result of these changes, but perhaps not significantly. The FDA's guidance is largely irrelevant to Paxlovid. We could even speculate that lower vaccination rates may actually lead to higher infection rates and more prescriptions for the medicine. Although Comirnaty's U.S. sales will be affected, the company reported just $2.004 billion in revenue from the U.S. coronavirus vaccine market last year, which accounts for about 37% of the total revenue Comirnaty generated. The U.S. market is the single most important for Pfizer. Overall, these new developments won't have a significant impact on its financial results. Even so, Pfizer continues to encounter headwinds, and this is yet another one. It might not be a big deal in a vacuum, but given Pfizer's trajectory since 2022, it's not exactly what investors want to see. Truth be told: Pfizer needs every single dollar it can collect in sales. Even slightly lower revenue than it expects from any medicine or vaccine is terrible news for a company whose midpoint revenue guidance of $62.5 billion for the year implies a slight decrease compared to 2024. In light of all this, it's fair for investors to look at the company's performance over the past few years and wonder whether it can bounce back. If it does, it will unlikely be because of its work in the coronavirus vaccine market. Pfizer has made significant strides in recent years to strengthen its pipeline. One of its latest moves was to expand its already robust portfolio of oncology candidates with the licensing of a promising cancer medicine, called SSGJ-707, originally developed by China-based 3S Bio. Pfizer dished out an upfront payment of $1.25 billion for this mid-stage asset, with potential milestone payments of up to $4.8 billion on top of royalties. Pfizer's comeback story will almost certainly include at least one, if not several, significant regulatory wins in oncology. Given its massive pipeline in the field and vast experience in developing drugs in this area, the drugmaker should be well-positioned to achieve this goal. Pfizer is working on numerous therapies in other fields as well and is enhancing its business in various ways. The healthcare company has decreased expenses and costs and plans to continue doing so until 2027. In my view, thanks to its equally massive success in the coronavirus market earlier this decade, we have yet to see the results of the massive investments Pfizer made in its pipeline, It's not time to give up on the stock just yet, even with the recent regulatory changes in the U.S. Pfizer could still generate excellent returns for patient investors. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy. Terrible News for Pfizer Stock Investors was originally published by The Motley Fool Sign in to access your portfolio

Schools in China Reportedly Isolate Students as COVID Cases Surge
Schools in China Reportedly Isolate Students as COVID Cases Surge

Epoch Times

time2 hours ago

  • Epoch Times

Schools in China Reportedly Isolate Students as COVID Cases Surge

Doctors and residents across China continue to report more infections and deaths as the latest wave of COVID-19 continues, portraying a far more severe situation than the Chinese regime is letting on. Schools in various provinces are reportedly suspending classes and placing students in quarantine, leading to growing concerns among the public of a return of lockdowns, according to information provided to the Chinese language version of The Epoch Times and on social media. A 'home quarantine notice,' issued by a primary school in Guangzhou and circulated by Chinese netizens on China's TikTok equivalent, Douyin, before being The notice said that a third-grade student was ordered to undergo quarantine for seven days after being diagnosed with COVID-19. After the quarantine period, health certificates from a clinic and community health service agency were required for the student to return to school. Schools in Shaanxi and Jiangsu also suspended classes after some students exhibited fevers, which were suspected to be COVID-19 infections. The Chinese communist regime's official data show that the COVID-19 infection rate doubled in April, with 168,507 cases, including 340 severe cases and nine deaths. The Chinese Center for Disease Control and Prevention (China CDC) said that infection rates in China's southern provinces were higher than that in the north. Related Stories 5/30/2025 5/31/2025 Chinese state media Xinhua reported on May 28 that, according to health officials, the upward trend of COVID-19 infections has slowed down, and in most provinces the epidemic has reached a peak or is on a downward trend. However, residents across the country told The Epoch Times the situation is far worse and that official data continue to not match their lived experience. Because of the CCP's history of covering up information and publishing unreliable data, including the underreporting of COVID-19 infections and related deaths since early 2020, accounts from local medical doctors and residents can offer valuable information for understanding the situation on the ground in the totalitarian country. Kang Hong, a doctor at a clinic in Guangzhou city in China's south who used a pseudonym for safety concerns, told The Epoch Times on May 29 that most of those infected with COVID-19 in this wave have been adults, although it has also affected children. 'Their symptoms are far more severe than the common cold,' he said, including the white-lung symptom often seen in COVID-19 patients. Kang said that most patients came to the clinic for symptoms of colds and fevers. He added that they are not being tested for COVID-19 'because hospitals in China had not conducted large-scale nucleic acid testing for a long time because it was worried about causing social panic.' Many patients are also unwilling to take a COVID-19 test, Kang said, 'because they know they are infected with the COVID-19 (based on their symptoms) and were unwilling to spend more than 100 yuan ($13.90) for testing.' Kang revealed that a doctor in a tertiary hospital in Guangzhou, where his daughter works, died from COVID-19 in recent days. 'It's a senior doctor who only got tested when his symptoms became serious, and the result was COVID-19,' Kang said. Kang added that although COVID-19 infections have increased, the local health bureau told the doctors that they do not need to report confirmed cases. Mr. Li, a resident of Guangzhou city who only gave his last name out of safety concerns, told The Epoch Times that there are many people around him who have had cold-like symptoms recently, including his whole family. Li said they were diagnosed with COVID-19 several times before, and believe their symptoms are another round of COVID-19. Mr. Guo, a resident in the adjacent Shenzhen city, told The Epoch Times that during the May Day holiday (May 1 to May 4), many people traveled and started to show cold symptoms that are likely COVID-19 afterwards. Meanwhile, residents in north China also reported a spike in COVID-19 infections. Liu Kun, the owner of a private clinic in Hohhot city in Inner Mongolia who gave the pseudonym for safety concerns, told The Epoch Times on May 30 that COVID-19 infections are ongoing, 'with many experiencing symptoms of coughing, sputum, vomiting and diarrhea.' He said there are many patients whose 'symptoms last for a long time—some even for months.' He predicted that based on the characteristics of this infectious disease, 'there may be an explosive growth in infections in June and July.' People wearing masks wait at an outpatient area of the respiratory department of a hospital in Beijing, China, on Jan. 8, 2025. Jade Gao/AFP via Getty Images Mr. Xu, a resident in Benxi city of Liaoning Province who only gave his surname out of safety concerns, told The Epoch Times that some of his friends and relatives have recently caught colds. 'We have already realized that it may be COVID-19 caused by a mutated virus. The symptoms have been dragging on and not getting better. It cannot be cured by medicine at all.' He added that there have been sudden deaths, especially concentrated around people in their 40s and 50s. The infections have also been rapidly spreading in Shanxi Province, Mr. Luo, a resident of Changzhi city who only gave his surname, told The Epoch Times. 'My family members—including my wife, daughter, son-in-law, and granddaughter—have all been infected,' he said. Fear of Zero-COVID Restrictions The school suspensions and quarantines have heightened public concern that the regime's draconian zero-COVID restrictions employed from 2020 to the end of 2022—during which communities were locked down, mass testing was mandatory, travel was restricted, and residents were forcefully sent to quarantine centers—could make a comeback. Dr. Jonathan Liu, director of Liu's Wisdom Healing Centre and a professor at Canada Public College, told The Epoch Times on May 30 that although mainland China is experiencing another wave of COVID-19 infections, the official data hasn't indicated a serious spread that requires the lockdown of cities. 'Following the continuing strategy of concealment, the Chinese regime does not want to shut down the cities or implement the zero-COVID policy at the moment because that will seriously affect its economic development. Now, stimulating economic development is the regime's top priority,' Liu said. Sean Lin, assistant professor in the Biomedical Science Department at Feitian College and former U.S. army microbiologist, shares a similar assessment. 'The authorities won't immediately adopt the lockdown measure because they also know that if they implement the strict zero-COVID policy, it will cause a huge backlash from the public,' Lin told The Epoch Times on May 30. 'So the government is now building mobile cabin hospitals or temporary isolation facilities in various regions to quietly take people away. There may not be major changes in policy announced to the public,' he said. The Chinese language edition of The Epoch Times reported earlier this year that, according to insiders in some parts of China, local governments were building large scale mobile cabin hospitals to quarantine patients with respiratory infections, including COVID-19, such as in Urumqi in Xinjiang region and in several provinces. Employees work at a makeshift hospital that will be used for COVID-19 coronavirus patients in Guangzhou, in China's eastern Guangdong province on April 11, 2022. AFP via Getty Images Lin said that some places may have adopted measures to let people stay at home for quarantine 'but it will not turn into a large-scale policy unless the regime is unstable and the authorities have to take such measures. It has not reached that point yet.' The China CDC has yet to release its COVID-19 data for May but did update its weekly influenza report, in which the number of infections increased significantly this week. According to the weekly influenza report for epidemiological week 21 (May 19 to 25), released May 29, a total of eight influenza-like outbreaks have been reported nationwide. In comparison, only one influenza-like outbreak was reported nationwide in week 20 and no influenza-like outbreaks were reported in week 19. Lin said that the authorities continue to cover-up real COVID data in China. 'The people do not know the real situation and the severity of the wave of outbreak, especially the severity rate and mortality rate. The authorities don't tell the people.' He said that China's situation is more complicated and severe, as 'it involves multiple respiratory pathogens co-circulating and co-infections, with three or four respiratory pathogens infecting at the same time, not just this NB.1.8.1 strain. But the officials have not revealed the real situation, so I think it is difficult for the international community to understand.' NB.1.8.1 Chinese health authorities announced on May 23 that Omicron variant NB.1.8.1 is currently the primary variant spreading across China, as detection of the variant increased in the international community. NB.1.8.1 is a sixth-generation sub-branch of the XDV variant. 'The current data does not show that the NB1.8.1 variant has a significant breakthrough in pathogenicity, but it has an almost 1.8-fold improvement in immune escape capability. If it replaces the previous dominant variant that caused COVID-19, it's because its transmission ability is enhanced,' Lin told The Epoch Times. He pointed out that new COVID variants have frequently emerged in the past three years. 'Often new strains quickly replace old ones to be the dominant one. This has become routine.' A person receives a COVID-19 vaccine at Los Angeles International Airport in Los Angeles on Dec. 22, 2021. Frederic J. Brown/AFP via Getty Images The World Health Organization (WHO) has As the wave of infections in China continues, However, Lin said there is no sign of a ban of travelers or flights from China by other countries 'because the WHO does not have accurate data from China.' 'According to the current monitoring of countries around the world, there has not been a rapid, large-scale increase in infections like in the one in 2020.' Lin said that because the Chinese regime does not reveal true data, 'it's not possible to track virus spreading routes.' 'This also brings about a greater danger,' he said. 'China often covers up many things until they can no longer be covered up. When they come out, the situation is already quite serious and may be out of control. This is actually the biggest concern.' Luo Ya, Fang Xiao, and Xiong Bin contributed to this report.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store